PMID- 35239671 OWN - NLM STAT- MEDLINE DCOM- 20220310 LR - 20221006 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 17 IP - 3 DP - 2022 TI - Deficiency in Lyst function leads to accumulation of secreted proteases and reduced retinal adhesion. PG - e0254469 LID - 10.1371/journal.pone.0254469 [doi] LID - e0254469 AB - Chediak-Higashi syndrome, caused by mutations in the Lysosome Trafficking Regulator (Lyst) gene, is a recessive hypopigmentation disorder characterized by albinism, neuropathies, neurodegeneration, and defective immune responses, with enlargement of lysosomes and lysosome-related organelles. Although recent studies have suggested that Lyst mutations impair the regulation of sizes of lysosome and lysosome-related organelle, the underlying pathogenic mechanism of Chediak-Higashi syndrome is still unclear. Here we show striking evidence that deficiency in LYST protein function leads to accumulation of photoreceptor outer segment phagosomes in retinal pigment epithelial cells, and reduces adhesion between photoreceptor outer segment and retinal pigment epithelial cells in a mouse model of Chediak-Higashi syndrome. In addition, we observe elevated levels of cathepsins, matrix metallopeptidase (MMP) 3 and oxidative stress markers in the retinal pigment epithelium of Lyst mutants. Previous reports showed that impaired degradation of photoreceptor outer segment phagosomes causes elevated oxidative stress, which could consequently lead to increases of cysteine cathepsins and MMPs in the extracellular matrix. Taken together, we conclude that the loss of LYST function causes accumulation of phagosomes in the retinal pigment epithelium and elevation of several extracellular matrix-remodeling proteases through oxidative stress, which may, in turn, reduce retinal adhesion. Our work reveals previously unreported pathogenic events in the retinal pigment epithelium caused by Lyst deficiency. The same pathogenic events may be conserved in other professional phagocytic cells, such as macrophages in the immune system, contributing to overall Chediak-Higashi syndrome pathology. FAU - Ji, Xiaojie AU - Ji X AD - The Jackson Laboratory, Bar Harbor, ME, United States of America. AD - Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME, United States of America. FAU - Zhao, Lihong AU - Zhao L AD - The Jackson Laboratory, Bar Harbor, ME, United States of America. FAU - Umapathy, Ankita AU - Umapathy A AD - Department of Ophthalmology and Stein Eye Institute, University of California, Los Angeles, CA, United States of America. FAU - Fitzmaurice, Bernard AU - Fitzmaurice B AD - The Jackson Laboratory, Bar Harbor, ME, United States of America. FAU - Wang, Jieping AU - Wang J AD - The Jackson Laboratory, Bar Harbor, ME, United States of America. FAU - Williams, David S AU - Williams DS AD - Department of Ophthalmology and Stein Eye Institute, University of California, Los Angeles, CA, United States of America. AD - Department of Neurobiology, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America. AD - Molecular Biology Institute, UCLA, Los Angeles, CA, United States of America. AD - Brain Research Institute, UCLA, Los Angeles, CA, United States of America. FAU - Chang, Bo AU - Chang B AD - The Jackson Laboratory, Bar Harbor, ME, United States of America. FAU - Naggert, Jurgen K AU - Naggert JK AD - The Jackson Laboratory, Bar Harbor, ME, United States of America. FAU - Nishina, Patsy M AU - Nishina PM AUID- ORCID: 0000-0003-1640-5945 AD - The Jackson Laboratory, Bar Harbor, ME, United States of America. LA - eng GR - R01 EY011996/EY/NEI NIH HHS/United States GR - U54 AG054345/AG/NIA NIH HHS/United States GR - P30 CA034196/CA/NCI NIH HHS/United States GR - P30 EY000331/EY/NEI NIH HHS/United States GR - R01 EY019943/EY/NEI NIH HHS/United States GR - R01 EY027442/EY/NEI NIH HHS/United States GR - R01 EY027860/EY/NEI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20220303 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - EC 3.4.- (Peptide Hydrolases) SB - IM MH - *Peptide Hydrolases PMC - PMC8893605 COIS- The authors declare no conflict of interest. EDAT- 2022/03/04 06:00 MHDA- 2022/03/11 06:00 PMCR- 2022/03/03 CRDT- 2022/03/03 17:14 PHST- 2021/06/16 00:00 [received] PHST- 2022/02/18 00:00 [accepted] PHST- 2022/03/03 17:14 [entrez] PHST- 2022/03/04 06:00 [pubmed] PHST- 2022/03/11 06:00 [medline] PHST- 2022/03/03 00:00 [pmc-release] AID - PONE-D-21-19819 [pii] AID - 10.1371/journal.pone.0254469 [doi] PST - epublish SO - PLoS One. 2022 Mar 3;17(3):e0254469. doi: 10.1371/journal.pone.0254469. eCollection 2022.